Alexander Hardy
Chief Executive Officer at BioMarin Pharmaceutical Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 2 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 90
- Earnings growth 15%
- 100
15.4% a year in revenue
33.9% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioMarin Pharmaceutical Inc. June 2, 202699.4%
-
BioMarin Pharmaceutical Inc. May 20, 202599.4%
-
BioMarin Pharmaceutical Inc. May 21, 202499.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −4,252 | $56.05 | $238,325 |
| Mar 16, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +62,440 | — | — |
| Mar 13, 2026 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −2,941 | $58.51 | $172,078 |
| Dec 1, 2025 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −16,570 | $55.03 | $911,847 |
| Apr 30, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +375 | $54.14 | $20,303 |
| Mar 17, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +44,360 | — | — |
| Mar 14, 2025 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −2,933 | $69.44 | $203,668 |
| Nov 29, 2024 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −14,295 | $66.03 | $943,899 |
| Oct 31, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +300 | $56.01 | $16,803 |
| Mar 15, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +32,780 | — | — |
| Dec 1, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +68,039 | — | — |
| Dec 1, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +47,332 | — | — |
Questions about Alexander Hardy
What boards is Alexander Hardy on?
Alexander Hardy sits on the board of BioMarin Pharmaceutical Inc.
What company is Alexander Hardy the CEO of?
Alexander Hardy has been Chief Executive Officer of BioMarin Pharmaceutical Inc. since December 2023.
How long has Alexander Hardy served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.